The potential role of osteoporosis in unspecific [
Bone uptake
Osteoporosis
PET/CT
PET/MRI
PSMA
Prostate cancer
[18F]PSMA-1007
Journal
European journal of nuclear medicine and molecular imaging
ISSN: 1619-7089
Titre abrégé: Eur J Nucl Med Mol Imaging
Pays: Germany
ID NLM: 101140988
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
received:
12
06
2023
accepted:
31
08
2023
medline:
29
11
2023
pubmed:
12
9
2023
entrez:
12
9
2023
Statut:
ppublish
Résumé
Unspecific bone uptake is one of the main limitations of PET imaging with some PSMA-targeting radiopharmaceuticals, especially with [ We retrospectively analyzed treatment-naïve patients with a confirmed diagnosis of prostate adenocarcinoma who underwent staging [ We analyzed 77 patients: 29 of them (38%) had unspecific bone uptake at [ We observed unspecific bone uptake on [
Identifiants
pubmed: 37698646
doi: 10.1007/s00259-023-06424-9
pii: 10.1007/s00259-023-06424-9
doi:
Substances chimiques
Gallium Radioisotopes
0
PSMA-1007
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
304-311Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Alberts IL, Seide SE, Mingels C, Bohn KP, Shi K, Zacho HD, et al. Comparing the diagnostic performance of radiotracers in recurrent prostate cancer: a systematic review and network meta-analysis. Eur J Nucl Med Mol Imaging; 2021;48:2978–89.
Rauscher I, Krönke M, König M, Gafita A, Maurer T, Horn T, et al. Matched-pair comparison of 68Ga-PSMA-11 PET/CT and 18F-PSMA-1007 PET/CT: frequency of pitfalls and detection efficacy in biochemical recurrence after radical prostatectomy. J Nucl Med. 2020;61:51.
Arnfield EG, Thomas PA, Roberts MJ, Pelecanos AM, Ramsay SC, Lin CY, et al. Clinical insignificance of [18F]PSMA-1007 avid non-specific bone lesions: a retrospective evaluation. Eur J Nucl Med Mol Imaging. 2021;48:4495–507.
Pattison DA, Debowski M, Gulhane B, Arnfield EG, Pelecanos AM, Garcia PL, et al. Prospective intra-individual blinded comparison of [18F]PSMA-1007 and [68 Ga]Ga-PSMA-11 PET/CT imaging in patients with confirmed prostate cancer. Eur J Nucl Med Mol Imaging. 2022;49:763–776.
Seifert R, Telli T, Opitz M, Barbato F, Berliner C, Nader M, et al. Unspecific PSMA-1007 bone uptake evaluated through PSMA-11 PET, bone scan and MRI triple validation in patients with biochemical recurrence of prostate cancer. J Nucl Med. 2023;64(5):738–743.
Hoberück S, Löck S, Borkowetz A, Sommer U, Winzer R, Zöphel K, et al. Intraindividual comparison of [68 Ga]-Ga-PSMA-11 and [18F]-F-PSMA-1007 in prostate cancer patients: a retrospective single-center analysis. EJNMMI Res. 2021;11(1):109.
Phelps TE, Harmon SA, Mena E, Lindenberg L, Shih JH, Citrin DE, et al. Predicting outcomes of indeterminate bone lesions on 18 F-DCFPyL PSMA PET/CT scans in the setting of high-risk primary or recurrent prostate cancer. J Nucl Med. 2023;64(3):395–401.
Hammes J, Hohberg M, Täger P, Wild M, Zlatopolskiy B, Krapf P, et al. Uptake in non-affected bone tissue does not differ between [18F]-DCFPyL and [68Ga]-HBED-CC PSMA PET/CT. PLoS One. Public Library of Science; 2018;13:e0209613.
Grünig H, Maurer A, Thali Y, Kovacs Z, Strobel K, Burger IA, et al. Focal unspecific bone uptake on [18F]-PSMA-1007 PET: a multicenter retrospective evaluation of the distribution, frequency, and quantitative parameters of a potential pitfall in prostate cancer imaging. Eur J Nucl Med Mol Imaging. Springer; 2021;48:4483.
Ioppolo JA, Nezich RA, Richardson KL, Morandeau L, Leedman PJ, Price RI. Direct in vivo comparison of [18F]PSMA-1007 with [68Ga]Ga-PSMA-11 and [18F]AlF-PSMA-11 in mice bearing PSMA-expressing xenografts. Appl Radiat Isot. Pergamon; 2020;161:109164.
Piron S, Verhoeven J, Descamps B, Kersemans K, De Man K, Van Laeken N, et al. Intra-individual dynamic comparison of 18F-PSMA-11 and 68Ga-PSMA-11 in LNCaP xenograft bearing mice. Sci Rep. 2020;10(1):21068.
Silver DA, Pellicer I, Fair WR, Heston WDW, Cordon-Cardo C. Prostate-specific membrane antigen expression in normal and malignant human tissues. Clin Cancer Res. 1997;3(1):1–5.
Maisto C, Aurilio M, Morisco A, De Marino R, Buonanno Recchimuzzo MJ, Carideo L, et al. Analysis of pros and cons in using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007: production, costs, and PET/CT applications in patients with prostate cancer. Molecules. 2022;27(12):3862.
doi: 10.3390/molecules27123862
pubmed: 35744985
pmcid: 9227284
Shigematsu Y, Hirai T, Kawanaka K, Shiraishi S, Yoshida M, Kitajima M, et al. Distinguishing Imaging features between spinal hyperplastic hematopoietic bone marrow and bone metastasis. Am J Neuroradiol. 2014;35:2013–20.
Fibrous Dysplasia - StatPearls - NCBI Bookshelf [Internet]. [cited 2023 May 3]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK532947/#!po=50.0000 . Accessed 3 May 2023
Appelman-Dijkstra NM, Papapoulos SE. Paget’s disease of bone. Best Pract Res Clin Endocrinol Metab. Baillière Tindall; 2018;32:657–68.
Shellock FG, Morris E, Deutsch AL, Mink JH, Kerr R, Boden SD. Hematopoietic bone marrow hyperplasia: high prevalence on MR images of the knee in asymptomatic marathon runners. Am J Roentgenol. American Public Health Association; 1992;158:335–8.
Salari N, Darvishi N, Bartina Y, Larti M, Kiaei A, Hemmati M, et al. Global prevalence of osteoporosis among the world older adults: a comprehensive systematic review and meta-analysis. J Orthop Surg Res. BioMed Central Ltd; 2021;16:1–13.
Li Y, Hao W, Guan J, Li B, Meng L, Sun S, et al. Relationship between indices of circulating blood cells and bone homeostasis in osteoporosis. Front Endocrinol (Lausanne). Frontiers Media S.A.; 2022;13:2163.
Dé Rique Turcotte Id A-F, O’connor S, Morin SN, Gibbs JC, Willie BM, Jean S, et al. Association between obesity and risk of fracture, bone mineral density and bone quality in adults: a systematic review and meta-analysis. PLoS One. 2021;16(6):e0252487.
Vadera S, Osborne T, Shah V, Stephenson JA. Opportunistic screening for osteoporosis by abdominal CT in a British population. Insights into imaging 2023 141. SpringerOpen; 2023;14:1–8.
Fendler WP, Eiber M, Beheshti M, Bomanji J, Calais J, Ceci F, et al. PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0. Eur J Nucl Med Mol Imaging. Springer Berlin Heidelberg; 2023;1466–86.
Li H, Zhang X, Zhang Q, Zhang Q, Zhu X, Xie T, et al. The relationship between the monocyte-to-lymphocyte ratio and osteoporosis in postmenopausal females with T2DM: a retrospective study in Chinese population. Front Endocrinol (Lausanne). 2023;14:1–7.
Gao K, Zhu W, Liu W, Ma D, Li H, Yu W, et al. The predictive role of monocyte-to-lymphocyte ratio in osteoporosis patient. Med (United States). Lippincott Williams and Wilkins; 2019;98.
Lee JH, Kim JH, Hong AR, Kim SW, Shin CS. Optimal body mass index for minimizing the risk for osteoporosis and type 2 diabetes. Korean J Intern Med. 2020;35:1432–42.
doi: 10.3904/kjim.2018.223
pubmed: 31564086
Pickhardt PJ, Pooler BD, Lauder T, del Rio AM, Bruce RJ, Binkley N. Opportunistic screening for osteoporosis using abdominal computed tomography scans obtained for other indications. Ann Intern Med. 2013;158:588–95.
doi: 10.7326/0003-4819-158-8-201304160-00003
pubmed: 23588747
pmcid: 3736840
Jang S, Graffy PM, Ziemlewicz TJ, Lee SJ, Summers RM, Pickhardt PJ. Opportunistic osteoporosis screening at routine abdominal and thoracic CT: normative L1 trabecular attenuation values in more than 20 000 adults. Radiology. Radiological Society of North America Inc.; 2019;291:360–7.
Palumbo C, Dalla Volta A, Zamboni S, Mazziotti G, Zamparini M, Triggiani L, et al. Effect of Degarelix administration on bone health in prostate cancer patients without bone metastases. The Blade study. J Clin Endocrinol Metab. 2022;107(12):3398–3407.
Dalla Volta A, Palumbo C, Zamboni S, Mazziotti G, Triggiani L, Zamparini M, et al. Heterogeneity in regional changes in body composition induced by androgen deprivation therapy in prostate cancer patients: potential impact on bone health-the BLADE study. J Clin Endocrinol Invest. 2023. https://doi.org/10.1007/s40618-023-02150-z .
doi: 10.1007/s40618-023-02150-z
Takayanagi H. New developments in osteoimmunology. Nat Rev Rheumatol. 2012;8:684–9.
doi: 10.1038/nrrheum.2012.167
pubmed: 23070645
Tuckermann J, Adams RH. Crosstalk between endothelial cells and bone in development, homeostasis and inflammatory disease. Nat Rev Rheumatol. Europe PMC Funders; 2021;17:608.
Ganguly P, El-Jawhari JJ, Giannoudis PV, Burska AN, Ponchel F, Jones EA. Age-related changes in bone marrow mesenchymal stromal cells: a potential impact on osteoporosis and osteoarthritis development. Cell Transplant. 2017;26:1520–9.
doi: 10.1177/0963689717721201
pubmed: 29113463
pmcid: 5680949
Morimoto R, Uehara S, Yatsushiro S, Juge N, Hua Z, Senoh S, et al. Secretion of L-glutamate from osteoclasts through transcytosis. EMBO J. 2006;25:4175–86.
doi: 10.1038/sj.emboj.7601317
pubmed: 16957773
pmcid: 1570443
Riggs BL, Khosla S, Melton LJ. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev. 2002;23:279–302.
doi: 10.1210/edrv.23.3.0465
pubmed: 12050121
Barrett-Connor E, Nielson CM, Orwoll E, Bauer DC, Cauley JA. Epidemiology of rib fractures in older men: Osteoporotic Fractures in Men (MrOS) prospective cohort study. BMJ. BMJ Publishing Group; 2010;340:798.
Prins JTH, Van Lieshout EMM, Reijnders MRL, Verhofstad MHJ, Wijffels MME. Rib fractures after blunt thoracic trauma in patients with normal versus diminished bone mineral density: a retrospective cohort study. Osteoporos Int. 2020;31(2):225–231.
Krappinger D, Kammerlander C, Hak DJ, Blauth M. Low-energy osteoporotic pelvic fractures. Arch Orthop Trauma Surg. 2010;130(9):1167–75.
Kannus P, Palvanen M, Niemi S, Parkkari J, Järvinen M. Epidemiology of osteoporotic pelvic fractures in elderly people in Finland: sharp increase in 1970–1997 and alarming projections for the new millennium. Osteo Int. 2000;11(5):443.8.
Kuo TR, Chen CH. Bone biomarker for the clinical assessment of osteoporosis: recent developments and future perspectives. Biomark Res. 2017;5:18.
Watts NB, Adler RA, Bilezikian JP, Drake MT, Eastell R, Orwoll ES, et al. Osteoporosis in men: an endocrine society clinical practice guideline. J Clin Endocrinol Metab Oxford Academic. 2012;97:1802–22.
doi: 10.1210/jc.2011-3045
Vollnberg B, Alberts I, Genitsch V, Rominger A, Afshar-Oromieh A. Assessment of malignancy and PSMA expression of uncertain bone foci in [18F]PSMA-1007 PET/CT for prostate cancer-a single-centre experience of PET-guided biopsies. Eur J Nucl Med Mol Imaging. 2022;49:3910–6.
Chen MY, Franklin A, Yaxley J, Gianduzzo T, McBean R, Wong D, et al. Solitary rib lesions showing prostate-specific membrane antigen (PSMA) uptake in pre-treatment staging 68 Ga-PSMA-11 positron emission tomography scans for men with prostate cancer: benign or malignant? BJU Int. 2020;126:396–401.
doi: 10.1111/bju.15152
pubmed: 32592330